These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 32476013)
1. Proton pump inhibitors do not increase the risk of dementia: a systematic review and meta-analysis of prospective studies. Desai M; Nutalapati V; Srinivasan S; Fathallah J; Dasari C; Chandrasekhar VT; Mohammad B; Kohli D; Vaezi M; Katz PO; Sharma P Dis Esophagus; 2020 Oct; 33(10):. PubMed ID: 32476013 [TBL] [Abstract][Full Text] [Related]
2. Proton pump inhibitor use does not increase dementia and Alzheimer's disease risk: An updated meta-analysis of published studies involving 642305 patients. Song YQ; Li Y; Zhang SL; Gao J; Feng SY PLoS One; 2019; 14(7):e0219213. PubMed ID: 31265473 [TBL] [Abstract][Full Text] [Related]
3. No association between proton pump inhibitor use and risk of dementia: Evidence from a meta-analysis. Hussain S; Singh A; Zameer S; Jamali MC; Baxi H; Rahman SO; Alam M; Altamish M; Singh AK; Anil D; Hussain MS; Ahmad A; Najmi AK J Gastroenterol Hepatol; 2020 Jan; 35(1):19-28. PubMed ID: 31334885 [TBL] [Abstract][Full Text] [Related]
4. Proton pump inhibitor use and risk of dementia: Systematic review and meta-analysis. Li M; Luo Z; Yu S; Tang Z Medicine (Baltimore); 2019 Feb; 98(7):e14422. PubMed ID: 30762748 [TBL] [Abstract][Full Text] [Related]
5. Time-Varying Use of Proton Pump Inhibitors and Cognitive Impairment and Dementia: A Real-World Analysis from Germany. Ahn N; Wawro N; Baumeister SE; Nolde M; Gerlach R; Tauscher M; Günter A; Güntner F; Rückert-Eheberg IM; Meisinger C; Linseisen J Drugs Aging; 2023 Jul; 40(7):653-663. PubMed ID: 37178361 [TBL] [Abstract][Full Text] [Related]
6. Do proton pump inhibitors increase the risk of dementia? A systematic review, meta-analysis and bias analysis. Ahn N; Nolde M; Krause E; Güntner F; Günter A; Tauscher M; Gerlach R; Meisinger C; Linseisen J; Baumeister SE; Rückert-Eheberg IM Br J Clin Pharmacol; 2023 Feb; 89(2):602-616. PubMed ID: 36331350 [TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitors use and dementia risk: a meta-analysis of cohort studies. Zhang Y; Liang M; Sun C; Song EJ; Cheng C; Shi T; Min M; Sun Y Eur J Clin Pharmacol; 2020 Feb; 76(2):139-147. PubMed ID: 31748819 [TBL] [Abstract][Full Text] [Related]
8. No association between acid suppressant use and risk of dementia: an updated meta-analysis. Wang H; Tian L; Yan X Eur J Clin Pharmacol; 2022 Mar; 78(3):375-382. PubMed ID: 34811582 [TBL] [Abstract][Full Text] [Related]
10. Risk of dementia from proton pump inhibitor use in Asian population: A nationwide cohort study in Taiwan. Tai SY; Chien CY; Wu DC; Lin KD; Ho BL; Chang YH; Chang YP PLoS One; 2017; 12(2):e0171006. PubMed ID: 28199356 [TBL] [Abstract][Full Text] [Related]
11. Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis. Trifan A; Stanciu C; Girleanu I; Stoica OC; Singeap AM; Maxim R; Chiriac SA; Ciobica A; Boiculese L World J Gastroenterol; 2017 Sep; 23(35):6500-6515. PubMed ID: 29085200 [TBL] [Abstract][Full Text] [Related]
12. Proton pump inhibitors and dementia risk: Evidence from a cohort study using linked routinely collected national health data in Wales, UK. Cooksey R; Kennedy J; Dennis MS; Escott-Price V; Lyons RA; Seaborne M; Brophy S PLoS One; 2020; 15(9):e0237676. PubMed ID: 32946449 [TBL] [Abstract][Full Text] [Related]
13. Proton-pump inhibitors use, and risk of acute kidney injury: a meta-analysis of observational studies. Yang Y; George KC; Shang WF; Zeng R; Ge SW; Xu G Drug Des Devel Ther; 2017; 11():1291-1299. PubMed ID: 28479851 [TBL] [Abstract][Full Text] [Related]
14. Vitamin B12 deficiency and use of proton pump inhibitors: a systematic review and meta-analysis. Choudhury A; Jena A; Jearth V; Dutta AK; Makharia G; Dutta U; Goenka M; Kochhar R; Sharma V Expert Rev Gastroenterol Hepatol; 2023 May; 17(5):479-487. PubMed ID: 37060552 [TBL] [Abstract][Full Text] [Related]
15. Association of Proton Pump Inhibitors With Risk of Dementia: A Pharmacoepidemiological Claims Data Analysis. Gomm W; von Holt K; Thomé F; Broich K; Maier W; Fink A; Doblhammer G; Haenisch B JAMA Neurol; 2016 Apr; 73(4):410-6. PubMed ID: 26882076 [TBL] [Abstract][Full Text] [Related]
16. Systematic review with meta-analysis: the risks of proton pump inhibitors during pregnancy. Li CM; Zhernakova A; Engstrand L; Wijmenga C; Brusselaers N Aliment Pharmacol Ther; 2020 Feb; 51(4):410-420. PubMed ID: 31909512 [TBL] [Abstract][Full Text] [Related]
17. Cumulative Use of Proton Pump Inhibitors and Risk of Dementia: The Atherosclerosis Risk in Communities Study. Northuis CA; Bell EJ; Lutsey PL; George KM; Gottesman RF; Mosley TH; Whitsel EA; Lakshminarayan K Neurology; 2023 Oct; 101(18):e1771-e1778. PubMed ID: 37558503 [TBL] [Abstract][Full Text] [Related]
18. Proton pump inhibitors and risk of hip fracture: a meta-analysis of observational studies. Poly TN; Islam MM; Yang HC; Wu CC; Li YJ Osteoporos Int; 2019 Jan; 30(1):103-114. PubMed ID: 30539272 [TBL] [Abstract][Full Text] [Related]
19. Emulating a target trial of proton pump inhibitors and dementia risk using claims data. Ahn N; Nolde M; Günter A; Güntner F; Gerlach R; Tauscher M; Amann U; Linseisen J; Meisinger C; Rückert-Eheberg IM; Baumeister SE Eur J Neurol; 2022 May; 29(5):1335-1343. PubMed ID: 35170158 [TBL] [Abstract][Full Text] [Related]